Department of Microbiology and Immunology, USA; Department of Chemistry and Chemical Biology, USA; Cornell Center for Immunology, USA; Cornell Institute of Host-Microbe Interactions and Disease, USA; Cornell Center for Innovative Proteomics, Cornell University, Ithaca, NY 14853, USA.
Curr Opin Chem Biol. 2024 Dec;83:102539. doi: 10.1016/j.cbpa.2024.102539. Epub 2024 Oct 25.
The gut microbiome impacts many physiological processes that greatly influence host health and disease. Metabolites produced by the gut microbiota have emerged as central players in regulating these biological pathways, often through the engagement of specific host receptors. Despite the importance of these microbial metabolites and receptors in human biology, the vast majority of these interactions remain uncharted due to the complex nature of the gut microbiome and the multitude of metabolites that these microbes produce. Here, we highlight recent developments in identifying such host-gut microbiota interactions, including characterization of bioactive metabolites and their mechanisms of action. Understanding these pathways will enable the development of prophylactics and therapeutics for treating many inflammatory diseases that are impacted by the gut microbiota.
肠道微生物组影响着许多生理过程,这些过程对宿主的健康和疾病有着重大影响。肠道微生物产生的代谢物已成为调节这些生物途径的核心因素,通常是通过与特定的宿主受体结合来实现的。尽管这些微生物代谢物和受体在人类生物学中具有重要意义,但由于肠道微生物组的复杂性以及这些微生物产生的大量代谢物,这些相互作用中的绝大多数仍未被发现。在这里,我们强调了最近在鉴定这些宿主-肠道微生物组相互作用方面的进展,包括生物活性代谢物的特性及其作用机制。了解这些途径将有助于开发预防和治疗受肠道微生物组影响的许多炎症性疾病的药物。